Who Buys Cetuximab from India — 51 Importers Behind a $839.4K Market

The importers of Cetuximab from India can be categorized into several segments:

1. Distributors: Entities that procure Cetuximab for resale to healthcare providers. Their purchasing patterns typically involve bulk orders to maintain inventory levels and meet market demand.

2. Hospital Groups: Healthcare institutions acquiring Cetuximab for patient treatment. Their procurement is often based on patient needs and treatment protocols, leading to consistent, smaller-volume purchases.

3. Government Procurement Agencies: Organizations responsible for acquiring medications for public healthcare systems. They usually engage in tender-based purchasing, resulting in large, periodic orders.

4. Re-exporters: Companies that import Cetuximab with the intent to export it to other markets. Their buying behavior is influenced by global demand and trade regulations, leading to variable order sizes and frequencies.

5. Contract Manufacturers: Firms that import Cetuximab as part of their manufacturing processes for producing finished pharmaceutical products. Their procurement is aligned with production schedules and client requirements.

Among the top 10 buyers:

• AS PER INVOICE TURKEY (Turkey): Likely a distributor, given the generic naming convention, indicating bulk purchasing for distribution within Turkey.

• JOSE RONALDO DE DEUS (Brazil): Possibly a distributor or a representative of a hospital group, suggesting procurement for local distribution or direct patient care.

• INDIRA GANDHI MEMORIAL HOSPITAL (Maldives): A hospital group, indicating direct procurement for patient treatment within the institution.

• THE PURCHASE MANAGER HEALTH CITY CAYMAN ISLAND LIMITED (United Kingdom): Likely a hospital group, with the purchase manager representing the institution's procurement activities.

• PHARMACIE ARC EN CIEL COCODY (Côte d'Ivoire): A retail pharmacy, suggesting procurement for direct sale to patients.

For the top five importing countries, the import regulations for Cetuximab are as follows:

The demand for Cetuximab in importing countries is primarily driven by the increasing prevalence of cancers, particularly colorectal and head and neck cancers, where Cetuximab has proven efficacy. For instance, the global incidence of colorectal cancer is rising, necessitating effective treatment options like Cetuximab. Additionally, advancements in targeted therapies and personalized medicine have bolstered the adoption of Cetuximab, as it specifically targets the epidermal growth factor receptor (EGFR), leading to improved patient outcomes.

Government healthcare programs and the expansion of universal health coverage in various countries have also contributed to the increased demand for Cetuximab. Inclusion of Cetuximab in national formularies and its procurement through tender-based purchasing mechanisms have facilitated broader access. Furthermore, the World Health Organization's Essential Medicines List, which guides the procurement of vital medications, influences the adoption of Cetuximab in public health systems. The presence of 51 buyers across 30 countries, as per our data, underscores the global reach and market opportunity for Cetuximab imported from India.

The importers of Cetuximab from India can be categorized into several segments:

1. Distributors: Entities that procure Cetuximab for resale to healthcare providers. Their purchasing patterns typically involve bulk orders to maintain inventory levels and meet market demand.

2. Hospital Groups: Healthcare institutions acquiring Cetuximab for patient treatment. Their procurement is often based on patient needs and treatment protocols, leading to consistent, smaller-volume purchases.

3. Government Procurement Agencies: Organizations responsible for acquiring medications for public healthcare systems. They usually engage in tender-based purchasing, resulting in large, periodic orders.

4. Re-exporters: Companies that import Cetuximab with the intent to export it to other markets. Their buying behavior is influenced by global demand and trade regulations, leading to variable order sizes and frequencies.

5. Contract Manufacturers: Firms that import Cetuximab as part of their manufacturing processes for producing finished pharmaceutical products. Their procurement is aligned with production schedules and client requirements.

Among the top 10 buyers:

• AS PER INVOICE TURKEY (Turkey): Likely a distributor, given the generic naming convention, indicating bulk purchasing for distribution within Turkey.

• JOSE RONALDO DE DEUS (Brazil): Possibly a distributor or a representative of a hospital group, suggesting procurement for local distribution or direct patient care.

• INDIRA GANDHI MEMORIAL HOSPITAL (Maldives): A hospital group, indicating direct procurement for patient treatment within the institution.

• THE PURCHASE MANAGER HEALTH CITY CAYMAN ISLAND LIMITED (United Kingdom): Likely a hospital group, with the purchase manager representing the institution's procurement activities.

• PHARMACIE ARC EN CIEL COCODY (Côte d'Ivoire): A retail pharmacy, suggesting procurement for direct sale to patients.

For the top five importing countries, the import regulations for Cetuximab are as follows:

The demand for Cetuximab in importing countries is primarily driven by the increasing prevalence of cancers, particularly colorectal and head and neck cancers, where Cetuximab has proven efficacy. For instance, the global incidence of colorectal cancer is rising, necessitating effective treatment options like Cetuximab. Additionally, advancements in targeted therapies and personalized medicine have bolstered the adoption of Cetuximab, as it specifically targets the epidermal growth factor receptor (EGFR), leading to improved patient outcomes.

Government healthcare programs and the expansion of universal health coverage in various countries have also contributed to the increased demand for Cetuximab. Inclusion of Cetuximab in national formularies and its procurement through tender-based purchasing mechanisms have facilitated broader access. Furthermore, the World Health Organization's Essential Medicines List, which guides the procurement of vital medications, influences the adoption of Cetuximab in public health systems. The presence of 51 buyers across 30 countries, as per our data, underscores the global reach and market opportunity for Cetuximab imported from India.